Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DHR vs GSK✓SelectedUSD · GSKDHR vs GSK performance historyLatest closeAs of-0.45%11/19
Stock and ETF performance explorer

DHR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+241.1%
GSK return
+97.7%
Excess return
+143.4%
Maximum drawdown
-43.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%-1.6%+1.1%+0.2%
7D-2.0%-4.7%+2.7%-0.1%
30D+1.5%-4.7%+6.2%+3.3%
3M+7.8%-8.8%+16.5%+11.4%
6M+36.8%-4.6%+41.4%+38.5%
YTD0.0%+1.0%-1.0%-1.7%
1Y+3.1%+6.9%-3.8%-1.1%
3Y+11.5%+52.5%-41.1%-9.8%
5Y-16.2%+40.3%-56.5%-30.7%
All+241.1%+97.7%+143.4%+135.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling